Section 317 Vaccine Purchasing: The Challenge of Keeping Pace with New Vaccines
This AIM presentation was given at the CDC 2024 NIC on the Section 317 vaccine purchasing and the challenge of keeping pace with new vaccines.
This AIM presentation was given at the CDC 2024 NIC on the Section 317 vaccine purchasing and the challenge of keeping pace with new vaccines.
On September 18, AIM hosted the Annual Influenza Update Webinar. Attendees explored different strategies to prepare for the upcoming influenza season.
This report is a detailed overview of the 2023 Pediatric COVID-19 Vaccine Access Cooperative (VAC) meetings.
The webinar on September 13 reviewed the findings of a study conducted by AIM and Mathematica between June and September 2023.
A report on clinical providers’ experiences and perspectives in offering pediatric COVID-19 vaccinations.
A report on pharmacists’ experiences and perspectives in offering pediatric COVID-19 vaccinations and the feasibility of participation in the VFC program.
Read AIM’s 2023 Annual Report, which highlights the great work that AIM and AIM members achieved last year.
The September 10 Hot Topics discussion covered case updates, in the news, long COVID, and more.
View the 2025 Corporate Alliance brochure to read about program updates and benefits.
This report is a comprehensive review of all proposed, considered, enacted, and vetoed vaccine-related legislation that AIM monitored over the past year.